RETEAR
LIVE

Serial Number

88446352

Owner

ReTEAR, Inc.

Attorney

Katharine Tremblay

First Use Date

Jun 28, 2016

Filing Date

May 24, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RETEAR Trademark

Serial Number: 88446352

RETEAR is a trademark filed by ReTEAR, Inc. on May 24, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

ReTEAR, Inc.

San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

May 24, 2019

Registration Date

Not Registered

First Use Anywhere

June 28, 2016

First Use in Commerce

June 28, 2016

Published for Opposition

September 24, 2019

Goods & Services

Allergy medications; Homeopathic pharmaceuticals for use in the treatment of dry eye; Medical preparations for the treatment of dry eye; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment and prevention of dry eye; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of dry eye; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Plant and herb extracts sold as components of medicated cosmetics; Drug delivery agents in the form of dry eye that facilitate the delivery of pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparation for skin care; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for treating allergies; Pharmaceutical products for ophthalmological use

Filing History

ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 14, 2021 EXRA
SOU EXTENSION 3 GRANTED
Sep 12, 2021 EX3G
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2021 CRFA
NOTICE OF REVIVAL - E-MAILED
Aug 24, 2021 NREV
PETITION GRANTED - RESPONSE RECEIVED
Aug 24, 2021 PGRR
TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Jul 22, 2021 ERTP
ASSIGNED TO PETITION STAFF
Jun 29, 2021 APET
TEAS PETITION TO DIRECTOR RECEIVED
Jun 18, 2021 TPDR
EXAMINER'S AMENDMENT ENTERED
May 28, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 27, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
May 27, 2021 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
May 27, 2021 SNEA
SOU EXTENSION 3 FILED
May 19, 2021 EXT3
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 12, 2020 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2020 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Oct 21, 2020 SUPC
SOU EXTENSION 2 GRANTED
Oct 21, 2020 EX2G
USE AMENDMENT FILED
Oct 15, 2020 IUAF
SOU EXTENSION 2 FILED
Oct 15, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 15, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2020 EXRA
SOU EXTENSION 1 GRANTED
Aug 17, 2020 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 17, 2020 AITU
PETITION INQUIRY LETTER ISSUED
Jun 30, 2020 PILM
NOTICE OF REVIVAL - E-MAILED
Jun 23, 2020 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jun 22, 2020 TPEX
PETITION TO REVIVE-GRANTED
Jun 22, 2020 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 22, 2020 PROA
TEAS STATEMENT OF USE RECEIVED
Jun 22, 2020 EISU
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 22, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 22, 2020 ABN6
SOU EXTENSION 1 FILED
May 19, 2020 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 19, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 15, 2019 XAEC
ASSIGNED TO LIE
Aug 15, 2019 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 14, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 14, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 14, 2019 CNEA
ASSIGNED TO EXAMINER
Aug 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2019 NWOS
NEW APPLICATION ENTERED
May 28, 2019 NWAP